Covered recipient · General Payments record
DAVID LEE VALADEZ
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2021–2024
$813.53
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.72 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $187.33 | 8 |
| Janssen Biotech, Inc. | $56.12 | 3 |
| PFIZER INC. | $36.02 | 2 |
| Regeneron Healthcare Solutions, Inc. | $31.57 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $28.61 | 2 |
| Madrigal Pharmaceuticals | $21.91 | 1 |
| Ardelyx, Inc. | $14.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.72 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265188 | CMS |
| ABBVIE INC. | $23.90 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265190 | CMS |
| ABBVIE INC. | $8.82 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265192 | CMS |
| ABBVIE INC. | $22.97 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265194 | CMS |
| ABBVIE INC. | $20.06 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265196 | CMS |
| ABBVIE INC. | $28.91 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265198 | CMS |
| ABBVIE INC. | $25.15 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265200 | CMS |
| ABBVIE INC. | $23.80 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106265202 | CMS |
| Ardelyx, Inc. | $14.16 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712283 | CMS |
| Boston Scientific Corporation | $13.86 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092641462 | CMS |
| Boston Scientific Corporation | $14.75 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092641464 | CMS |
| Janssen Biotech, Inc. | $14.83 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078752178 | CMS |
| Janssen Biotech, Inc. | $18.17 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078753662 | CMS |
| Janssen Biotech, Inc. | $23.12 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078753040 | CMS |
| Madrigal Pharmaceuticals | $21.91 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144184627 | CMS |
| PFIZER INC. | $15.64 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132081120 | CMS |
| PFIZER INC. | $20.38 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131092769 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.57 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114231532 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.